The endpoints of the study by Arafat and colleagues were 30-day mortality, long-term survival, freedom from grade II or higher tricuspid valve regurgitation, change in the degree of tricuspid regurgitation during follow-up and tricuspid valve re-interventions. The Kaplan-Meier method was used to calculate survival at 1, 5, and 7 years, cumulative incidence for recurrent TR and reintervention. Follow-up was 97.8% complete. The median follow-up time was 53 months (25- 85 months).